Cargando…
Correlation between molar activity, injection mass and uptake of the PARP targeting radiotracer [(18)F]olaparib in mouse models of glioma
PURPOSE: Radiopharmaceuticals targeting poly(ADP-ribose) polymerase (PARP) have emerged as promising agents for cancer diagnosis and therapy. PARP enzymes are expressed in both cancerous and normal tissue. Hence, the injected mass, molar activity and potential pharmacological effects are important c...
Autores principales: | Chan, Chung Ying, Hopkins, Samantha L., Guibbal, Florian, Pacelli, Anna, Baguña Torres, Julia, Mosley, Michael, Lau, Doreen, Isenegger, Patrick, Chen, Zijun, Wilson, Thomas C., Dias, Gemma, Hueting, Rebekka, Gouverneur, Véronique, Cornelissen, Bart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548459/ https://www.ncbi.nlm.nih.gov/pubmed/36210377 http://dx.doi.org/10.1186/s13550-022-00940-9 |
Ejemplares similares
-
[(18)F]AZD2461, an Insight on Difference in PARP Binding Profiles for DNA Damage Response PET Imaging
por: Guibbal, Florian, et al.
Publicado: (2020) -
PET Imaging of PARP Expression Using (18)F-Olaparib
por: Wilson, Thomas C., et al.
Publicado: (2019) -
Imaging PARP with [(18)F]rucaparib in pancreatic cancer models
por: Chan, Chung Ying, et al.
Publicado: (2022) -
[(123)I]CC1: A PARP-Targeting, Auger Electron–Emitting Radiopharmaceutical for Radionuclide Therapy of Cancer
por: Chan, Chung Ying, et al.
Publicado: (2023) -
Radiofluorination of a highly potent ATM inhibitor as a potential PET imaging agent
por: Fraser, Claudia Rose, et al.
Publicado: (2022)